Literature DB >> 30786284

Free Vascularized Anterolateral Thigh Fascia Lata Flap for Reconstruction in Electrical Burns of the Severely Damaged Finger.

Xuekang Yang1, Zhuoqun Fang1, Mengdong Liu1, Yue Zhang1, Qiaohua Chen1, Ke Tao1, Juntao Han1, Dahai Hu1.   

Abstract

This study aimed to introduce a novel technique for reconstructing electricity-damaged fingers using a method combining the free vascularized anterolateral thigh fascia lata flap with skin grafting. From February 2015 to March 2017, 11 patients were enrolled in this retrospective case series. All patients suffered from electrical injury of the fingers and had severe soft tissue defects, with the exposure of tendon, vessels, or nerves. All finger wounds were covered using free vascularized anterolateral thigh fascia lata flaps combined with skin grafting. Eleven fascia flaps completely survived. Two patients suffered from partial grafting skin necrosis due to wound infection and subcutaneous hematoma, separately, which eventually healed after re-graft and dressing changes. All patients achieved satisfactory function and appearance without a need for repeated grafting. Except for the scar, no donor-site morbidity was reported. The present study provided an attractive option for treating electricity-damaged fingers with good outcomes and minimal donor-site morbidity.
© The Author(s) 2019. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 30786284     DOI: 10.1093/jbcr/irz010

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  1 in total

1.  Lateral Circumflex Femoral Vascular Chimeric Fascia Flap Reduces Pain and Promotes Wound Healing in Repairing Skin and Tendon Defects of Hand, Foot, and Ankle.

Authors:  Liming Xu; Jianshun Zhang; Faliang Shi; Renkuan Wang; Jianyan Wu
Journal:  Contrast Media Mol Imaging       Date:  2022-07-30       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.